CJ Bioscience to Present Preclinical Data on CJRB-201 at ECCO 2025; Clinical Entry in 2026
February 20, 2025
CJ Bioscience announced that it will present preclinical data on its novel drug candidate CJRB-201 at the European Crohn’s and Colitis Organization (ECCO) 2025, set to take